- Home
- NMG vs PRME Comparison
NMG vs PRME Comparison
Compare NMG & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- PRME
- Stock Information
- Founded
- NMG 2011
- PRME 2019
- Country
- NMG Canada
- PRME United States
- Employees
- NMG N/A
- PRME N/A
- Industry
- NMG Other Metals and Minerals
- PRME Medicinal Chemicals and Botanical Products
- Sector
- NMG Basic Materials
- PRME Health Care
- Exchange
- NMG Nasdaq
- PRME Nasdaq
- Market Cap
- NMG 341.1M
- PRME 379.1M
- IPO Year
- NMG 2017
- PRME 2022
- Fundamental
- Price
- NMG $1.69
- PRME $2.97
- Analyst Decision
- NMG Strong Buy
- PRME Strong Buy
- Analyst Count
- NMG 1
- PRME 9
- Target Price
- NMG $3.00
- PRME $13.13
- AVG Volume (30 Days)
- NMG 80.9K
- PRME 1.0M
- Earning Date
- NMG 03-27-2025
- PRME 03-04-2025
- Dividend Yield
- NMG N/A
- PRME N/A
- EPS Growth
- NMG N/A
- PRME N/A
- EPS
- NMG N/A
- PRME N/A
- Revenue
- NMG N/A
- PRME $800,000.00
- Revenue This Year
- NMG N/A
- PRME N/A
- Revenue Next Year
- NMG N/A
- PRME $477.62
- P/E Ratio
- NMG N/A
- PRME N/A
- Revenue Growth
- NMG N/A
- PRME N/A
- 52 Week Low
- NMG $1.22
- PRME $2.25
- 52 Week High
- NMG $2.82
- PRME $9.77
- Technical
- Relative Strength Index (RSI)
- NMG 38.52
- PRME 53.25
- Support Level
- NMG $1.78
- PRME $2.25
- Resistance Level
- NMG $2.07
- PRME $3.36
- Average True Range (ATR)
- NMG 0.13
- PRME 0.23
- MACD
- NMG -0.05
- PRME 0.07
- Stochastic Oscillator
- NMG 4.26
- PRME 64.41
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.